Latest News

AC Immune and Essex to develop biological treatment for neurodegenerative diseases

AC Immune and Essex to develop biological treatment for neurodegenerative diseases

Cancer Research UK funded scientists to test Zika virus on brain tumours

Scientists funded by Cancer Research UK will investigate the effectiveness of the Zika virus in destroying brain tumour cells, which could lead to new treatments for...

Cancer Research UK funded scientists to test Zika virus on brain tumours

Sobi receives SFDA approval for Orfadin capsules

Sobi receives SFDA approval for Orfadin capsules

X-Chem and Vertex form multi-target genetic disease collaboration

US-based firms X-Chem and Vertex Pharmaceuticals have signed a collaboration agreement to discover new drug leads against targets involved in multiple speciality...

X-Chem and Vertex form multi-target genetic disease collaboration

Bayer receives FDA priority review for copanlisib to treat follicular lymphoma

Bayer receives FDA priority review for copanlisib to treat follicular lymphoma

Eli Lilly Scores Phase III Migraine Success with Galcanezumab

Eli Lilly Scores Phase III Migraine Success with Galcanezumab

EU nations urge funding to research new drugs and vaccines for tuberculosis

Leaders representing the French and Netherlands governments have urged for funding to develop new treatment and prevention tools against drug-resistant tuberculosis (TB) at a meeting held in...

EU nations urge funding to research new drugs and vaccines for tuberculosis

US FDA issues CRL to Hikma’s generic version of GSK’s Advair Diskus

Hikma Pharmaceuticals has received a complete response letter (CRL) from the US Food and Drug Administration (FDA) for the abbreviated new drug application (ANDA) of its generic version...

US FDA issues CRL to Hikma’s generic version of GSK’s Advair Diskus

Exscientia signs collaboration deal with Sanofi for multiple product development

Artificial Intelligence-driven drug discovery firm Exscientia has formed a strategic research collaboration with Sanofi by signing a licence option agreement in the high-interest area of...

Exscientia signs collaboration deal with Sanofi for multiple product development

Immunocore and GSK identify second new ImmTAC for cancer treatment

UK-based biotechnology firm Immunocore and GlaxoSmithKline (GSK) have identified a lead compound as part of their second discovery...

Immunocore and GSK identify second new ImmTAC for cancer treatment

New collaborative project launched to engage universities in drug discovery for neglected diseases

A new collaborative project has been launched to engage students from five universities in the US, the UK and India to help discover new drugs for neglected...

New collaborative project launched to engage universities in drug discovery for neglected diseases

Dementia Discovery Fund to invest $5m in Cerevance to advance Alzheimer’s treatment

SV Life Sciences-managed Dementia Discovery Fund (DDF), which develops disease modifying drugs for dementia, has announced a $5m investment in the initial financing round of start-up drug...

Dementia Discovery Fund to invest $5m in Cerevance to advance Alzheimer’s treatment

Quay Pharmaceuticals receives permission to advance MedChew chewing gum development

The British Home Office has awarded relevant licences to Quay Pharmaceuticals, the product development partner of Axim Biotechnologies, to move forward with the development of Axim’s MedChew...

Quay Pharmaceuticals receives permission to advance MedChew chewing gum development

FDA approves Novartis Rydapt for acute myeloid leukaemia and mastocytosis

FDA approves Novartis Rydapt for acute myeloid leukaemia and mastocytosis

Takeda and Harrington Discovery Institute to advance rare disease therapeutics development

Takeda Pharmaceutical Company and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, have entered a multi-year collaboration to advance breakthrough therapeutic...

Takeda and Harrington Discovery Institute to advance rare disease therapeutics development

New study confirms effectiveness of BCM-95 to treat colitis, says Arjuna

New study confirms effectiveness of BCM-95 to treat colitis, says Arjuna

UK NCRI introduces five-year strategy to advance cancer research

The UK National Cancer Research Institute (NCRI) has launched a new five-year strategy to expedite cancer research through...

UK NCRI introduces five-year strategy to advance cancer research

Novartis obtains rights to use Parvus’ Navacim to develop products for T1D

Novartis obtains rights to use Parvus’ Navacim to develop products for T1D

Takeda and NuBiyota to develop microbial ecosystem therapeutic products for GI indications

Japanese company Takeda Pharmaceutical Company is all set to collaborate with NuBiyota to develop microbial ecosystem therapeutic products for gastroenterology (GI)...

Takeda and NuBiyota to develop microbial ecosystem therapeutic products for GI indications

Appili to develop new antibiotic to treat gram-negative infections

Anti-infective drug development company Appili Therapeutics is set to receive funding to support the development of a new antibiotic to treat gram-negative...

Appili to develop new antibiotic to treat gram-negative infections

Austrian scientists modify and reinforce host defence peptide from breast milk to detect cancer cells

Scientists at the University of Graz in Austria have modified and reinforced a host defence peptide from breast milk to enable it to specifically detect cancer...

Austrian scientists modify and reinforce host defence peptide from breast milk to detect cancer cells
cachename:Newscachekey:rd-137342983_-779801984_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_541212976